Filed: 8/13/2026ACC: 0001999371-26-017873
📋 What this filing means
GSK PLC filed this quarterly 13F‑HR report disclosing 13 equity positions with a total reported market value of $602.22M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
13
Positions
$602.22M
Total AUM (reported)
51.03M
Total Shares
Allocation by class
COM$181.02M30.1%
NAMEN AKT$175.65M29.2%
SHS$106.01M17.6%
SPONSORED ADS$89.28M14.8%
COM NEW$50.25M8.3%
Portfolio Concentration
Top 3$368.79M61.2%
4–10$218.51M36.3%
11–25$14.92M2.5%
Top 3 weight
61.2%
Top 10 weight
97.5%
Voting Authority Distribution
Total shares with voting rights: 51.03M
Sole
Full voting authority
51.03M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole13
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings13
Rows:
CRISPR THERAPEUTICS AG
SOLEShares3.22M
TypeSH
Market value$175.65M
29.17%
Sole
3.22M
Shared
0.00
None
0.00
WAVE LIFE SCIENCES LTD
SOLEShares18.25M
TypeSH
Market value$106.01M
17.60%
Sole
18.25M
Shared
0.00
None
0.00
VIR BIOTECHNOLOGY INC
SOLEShares8.55M
TypeSH
Market value$87.13M
14.47%
Sole
8.55M
Shared
0.00
None
0.00
BIONTECH SE
SOLEShares889.82K
TypeSH
Market value$82.80M
13.75%
Sole
889.82K
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares1.33M
TypeSH
Market value$49.69M
8.25%
Sole
1.33M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares340.43K
TypeSH
Market value$29.00M
4.82%
Sole
340.43K
Shared
0.00
None
0.00
LYELL IMMUNOPHARMA INC
SOLEShares1.51M
TypeSH
Market value$21.25M
3.53%
Sole
1.51M
Shared
0.00
None
0.00
SPERO THERAPEUTICS INC
SOLEShares9.19M
TypeSH
Market value$20.31M
3.37%
Sole
9.19M
Shared
0.00
None
0.00
NKARTA INC
SOLEShares3.15M
TypeSH
Market value$8.92M
1.48%
Sole
3.15M
Shared
0.00
None
0.00
FULCRUM THERAPEUTICS INC
SOLEShares1.79M
TypeSH
Market value$6.54M
1.09%
Sole
1.79M
Shared
0.00
None
0.00
BICYCLE THERAPEUTICS PLC
SOLEShares1.53M
TypeSH
Market value$6.49M
1.08%
Sole
1.53M
Shared
0.00
None
0.00
CVRX INC
SOLEShares1.01M
TypeSH
Market value$5.18M
0.86%
Sole
1.01M
Shared
0.00
None
0.00
REGENXBIO INC
SOLEShares271.46K
TypeSH
Market value$3.25M
0.54%
Sole
271.46K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 3.22M | SH | $175.65M 29.17% | 3.22M | 0.00 | 0.00 |
WAVE LIFE SCIENCES LTDSOLE | SHS | 18.25M | SH | $106.01M 17.60% | 18.25M | 0.00 | 0.00 |
VIR BIOTECHNOLOGY INCSOLE | COM | 8.55M | SH | $87.13M 14.47% | 8.55M | 0.00 | 0.00 |
BIONTECH SESOLE | SPONSORED ADS | 889.82K | SH | $82.80M 13.75% | 889.82K | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 1.33M | SH | $49.69M 8.25% | 1.33M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 340.43K | SH | $29.00M 4.82% | 340.43K | 0.00 | 0.00 |
LYELL IMMUNOPHARMA INCSOLE | COM NEW | 1.51M | SH | $21.25M 3.53% | 1.51M | 0.00 | 0.00 |
SPERO THERAPEUTICS INCSOLE | COM | 9.19M | SH | $20.31M 3.37% | 9.19M | 0.00 | 0.00 |
NKARTA INCSOLE | COM | 3.15M | SH | $8.92M 1.48% | 3.15M | 0.00 | 0.00 |
FULCRUM THERAPEUTICS INCSOLE | COM | 1.79M | SH | $6.54M 1.09% | 1.79M | 0.00 | 0.00 |
BICYCLE THERAPEUTICS PLCSOLE | SPONSORED ADS | 1.53M | SH | $6.49M 1.08% | 1.53M | 0.00 | 0.00 |
CVRX INCSOLE | COM | 1.01M | SH | $5.18M 0.86% | 1.01M | 0.00 | 0.00 |
REGENXBIO INCSOLE | COM | 271.46K | SH | $3.25M 0.54% | 271.46K | 0.00 | 0.00 |